PIK3CD and hepatocellular carcinoma: A PI3K inhibitor, LY294002 [29], dose-dependently suppressed the TGFα-induced AKT phosphorylation at both the serine and threonine residues in the HuH7 cells, suggesting that PI3K also regulates the AKT activity in HCC cells (Figure 2).